<DOC>
	<DOC>NCT00046501</DOC>
	<brief_summary>The purpose of the study is to compare the effect in blood sugar control between Lantus and twice daily intermediate acting insulins (NPH or Lente) when used as the basal insulin in a multiple daily injection setting with fast acting insulin (Lispro)</brief_summary>
	<brief_title>Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<mesh_term>Insulin, Isophane</mesh_term>
	<mesh_term>Isophane Insulin, Human</mesh_term>
	<criteria>Type 1 diabetes treated with insulin only for at least 1 year, with a Tanner stage of ≥ 2, had evidence of decreased insulin secretory capacity (fasting Cpeptide concentration ≤0.5 mmol/L) and 7.0%≤A1c≤9.5% at screening. The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.</criteria>
	<gender>All</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>